-
disrupt cellular energy metabolism and drive progressive dysfunction in neurodegenerative and neuromuscular disorders. The researcher will be based at the Institute of Biotechnology, University of
-
treatments for retinal disorders prevalent in the Finnish population and advancing promising therapeutic strategies toward clinical application. The group collaborates extensively with national and
Enter an email to receive alerts for disorders "https:" positions